Medicalgorithmics signs second commercial agreement for VCAST. Polish medtech strengthens its presence in promising Turkish market
Medicalgorithmics has signed a second commercial distribution agreement for VCAST -an AI platform for the analysis of coronary computed tomography angiography (CCTA). The Polish medtech company is expanding its collaboration with Turkish partner Ege Aritmi, which has been distributing Medicalgorithmics’ innovative AI software since March. Thanks to this new agreement, the company’s breakthrough cardiac imaging technology – which uses AI and competes with U.S.-based firms such as HeartFlow and Cleerly – will, after integration is completed, become available to clients in the promising Turkish market.